Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 5.94 1.37% 0.08
KALA closed up 1.37 percent on Friday, May 24, 2019, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical KALA trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 1.37%
Wide Bands Range Expansion 1.37%
Oversold Stochastic Weakness 1.37%
Wide Bands Range Expansion 0.34%
Oversold Stochastic Weakness 0.34%
Wide Bands Range Expansion 1.89%

Older signals for KALA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
Is KALA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.0
52 Week Low 4.03
Average Volume 177,807
200-Day Moving Average 7.9691
50-Day Moving Average 7.4662
20-Day Moving Average 6.614
10-Day Moving Average 5.925
Average True Range 0.3737
ADX 34.06
+DI 9.922
-DI 27.0513
Chandelier Exit (Long, 3 ATRs ) 6.918899999999999
Chandelier Exit (Short, 3 ATRs ) 6.7411
Upper Bollinger Band 8.1046
Lower Bollinger Band 5.1234
Percent B (%b) 0.27
BandWidth 45.074085
MACD Line -0.5
MACD Signal Line -0.4685
MACD Histogram -0.0315
Fundamentals Value
Market Cap 143.91 Million
Num Shares 24.2 Million
EPS -32.85
Price-to-Earnings (P/E) Ratio -0.18
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.22
Resistance 3 (R3) 6.20 6.09 6.17
Resistance 2 (R2) 6.09 6.02 6.10 6.16
Resistance 1 (R1) 6.02 5.98 6.05 6.03 6.14
Pivot Point 5.90 5.90 5.92 5.91 5.90
Support 1 (S1) 5.83 5.83 5.87 5.85 5.74
Support 2 (S2) 5.72 5.79 5.73 5.72
Support 3 (S3) 5.64 5.72 5.71
Support 4 (S4) 5.66